Cargando…

SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease

Mitochondria are essential for eukaryotic cell activity and function, and their dysfunction is associated with the development and progression of renal diseases. In recent years, there has been a rapid development in mitochondria-targeting pharmacological strategies as mitochondrial biogenesis, morp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuexin, Luo, Manyu, Bai, Xue, Li, Jicui, Nie, Ping, Li, Bing, Luo, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192202/ https://www.ncbi.nlm.nih.gov/pubmed/35707274 http://dx.doi.org/10.1155/2022/1295509

Ejemplares similares

Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications
por: Li, Jicui, et al.
Publicado: (2022)

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia
por: Ballarò, Riccardo, et al.
Publicado: (2021)

Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice
por: Yang, Shi-kun, et al.
Publicado: (2019)

Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia
por: Zhao, Hongting, et al.
Publicado: (2017)

Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study
por: Liu, Meiling, et al.
Publicado: (2023)

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
por: PANG, Yu, et al.
Publicado: (2015)

Targeting mitochondria in the aged cerebral vasculature with SS-31, a proteomic study of brain microvessels
por: Seman, Abigail, et al.
Publicado: (2023)

The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action
por: Mitchell, Wayne, et al.
Publicado: (2020)

SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease
por: Yang, Qianqian, et al.
Publicado: (2022)

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats
por: Lee, Fan-Yen, et al.
Publicado: (2018)

Synthesis, Characterization, and Specific Localization of Mitochondrial-Targeted Antioxidant Peptide SS31 Probe
por: He, Yuan, et al.
Publicado: (2021)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Influence of zinc levels and Nrf2 expression in the clinical and pathological changes in patients with diabetic nephropathy
por: Nie, Ping, et al.
Publicado: (2022)

The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
por: Grosser, Joshua A., et al.
Publicado: (2021)

Mitochondrial-Targeted Antioxidant Peptide SS31 Prevents RPE Cell Death under Oxidative Stress
por: He, Yuan, et al.
Publicado: (2022)

Platelet Membrane–Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury
por: Zhang, Zaiyuan, et al.
Publicado: (2022)

SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8
por: Hao, Zhi-Hua, et al.
Publicado: (2016)

Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2
por: Nie, Ping, et al.
Publicado: (2021)

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
por: Wu, Jing, et al.
Publicado: (2017)

Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH(2)) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury
por: Wyss, Jean-Christophe, et al.
Publicado: (2019)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Protective effects of SS31 on t-BHP induced oxidative damage in 661W cells
por: MA, WEI, et al.
Publicado: (2015)

Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet
por: Zhang, Meng, et al.
Publicado: (2017)

Evaluation of SS-31 as a Potential Therapeutic Target in the Treatment of Tendinopathy
por: Szeto, Hazel, et al.
Publicado: (2020)

Mitochondria-Targeted Self-Assembly of Peptide-Based Nanomaterials
por: Luo, Zhen, et al.
Publicado: (2021)

SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia
por: Yang, Qiaoyun, et al.
Publicado: (2022)

Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury
por: Zhao, Yue, et al.
Publicado: (2023)

Control release of mitochondria-targeted antioxidant by injectable self-assembling peptide hydrogel ameliorated persistent mitochondrial dysfunction and inflammation after acute kidney injury
por: Zhao, Meng, et al.
Publicado: (2018)

Adverse Neurological Effects of Short-Term Sleep Deprivation in Aging Mice Are Prevented by SS31 Peptide
por: Wu, Jinzi, et al.
Publicado: (2020)

Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China
por: Chen, Liangmei, et al.
Publicado: (2019)

Clinical and Pathological Analysis of 4910 Patients Who Received Renal Biopsies at a Single Center in Northeast China
por: Nie, Ping, et al.
Publicado: (2019)

The Mitochondria-Targeted Antioxidants and Remote Kidney Preconditioning Ameliorate Brain Damage through Kidney-to-Brain Cross-Talk
por: Silachev, Denis N., et al.
Publicado: (2012)

SS-31 Peptide Reverses the Mitochondrial Fragmentation Present in Fibroblasts From Patients With DCMA, a Mitochondrial Cardiomyopathy
por: Machiraju, Pranav, et al.
Publicado: (2019)

Treatment with the mitochondrial‐targeted antioxidant peptide SS‐31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice
por: Tarantini, Stefano, et al.
Publicado: (2018)

SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides
por: Kuang, Xiao, et al.
Publicado: (2017)

Mitochondrial-Targeting Antioxidant SS-31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke
por: Yang, De-qing, et al.
Publicado: (2021)

Targeting Mitochondria and Metabolism in Acute Kidney Injury
por: Li, Ying, et al.
Publicado: (2021)

ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
por: Liu, Di, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l0a3mtb9b1r1e0tpu6b2650pta